23. Prion disease Clinical trials / Disease details


Clinical trials : 4 Drugs : 5 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00183092
(ClinicalTrials.gov)
April 200514/9/2005CJD (Creutzfeldt-Jakob Disease) Quinacrine StudyNovel Therapeutics For Prion Diseases: A Randomized, Double-blinded, Placebo-controlled Study of the Efficacy of Quinacrine in the Treatment of Sporadic Creutzfeldt-Jakob DiseaseCreutzfeldt-Jakob DiseaseDrug: Quinacrine;Drug: PlaceboUniversity of California, San FranciscoNational Institute on Aging (NIA)Completed18 YearsN/AAll69Phase 2United States
2NCT00104663
(ClinicalTrials.gov)
June 20043/3/2005PRION-1: Quinacrine for Human Prion DiseasePRION-1: Quinacrine for Human Prion Disease. A Partially Randomized Patient Preference Trial to Evaluate the Activity and Safety of Quinacrine in Human Prion DiseasePrion DiseaseDrug: QuinacrineMedical Research CouncilNULLCompleted12 YearsN/ABoth160N/AUnited Kingdom